As adiponectin is known to play a role in insulin signaling and inflammatory pathways (Ouchi and Walsh, 2007), its reduction may be partially responsible for the onset of insulin resistance and systemic inflammation and T2DM pathophysiology. This evidence concerns the gene ADIPOQ and Insulin resistance.